Rhythm Pharmaceuticals Inc (RYTM) — Working Capital to Net Assets Ratio
Rhythm Pharmaceuticals Inc (RYTM) has a Working Capital to Net Assets ratio of 259.6% as of December 2025. Working capital of $360.97 Million (current assets of $466.92 Million minus current liabilities of $105.94 Million) is measured against net assets of $139.07 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See RYTM cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Rhythm Pharmaceuticals Inc Working Capital to Net Assets (2012–2025)
This chart shows how Rhythm Pharmaceuticals Inc's Working Capital to Net Assets ratio has evolved across 14 annual periods from 2012 to 2025. As of December 2025, the ratio stands at 259.6%, reflecting working capital of $360.97 Million against net assets of $139.07 Million USD. For the complete balance sheet picture, see Rhythm Pharmaceuticals Inc balance sheet assets.
Annual Working Capital to Net Assets for Rhythm Pharmaceuticals Inc (2012–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Rhythm Pharmaceuticals Inc from 2012 to 2025, covering 14 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check RYTM asset resilience ratio to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 259.6% | $360.97 Million | $139.07 Million | $466.92 Million | $105.94 Million | ▲ +102.4 pp |
| 2024 | 157.2% | $258.68 Million | $164.55 Million | $374.20 Million | $115.52 Million | ▲ +8.1 pp |
| 2023 | 149.1% | $253.06 Million | $169.76 Million | $308.27 Million | $55.20 Million | ▲ +30.1 pp |
| 2022 | 119.0% | $314.43 Million | $264.26 Million | $354.24 Million | $39.81 Million | ▲ +25.7 pp |
| 2021 | 93.2% | $264.96 Million | $284.15 Million | $308.39 Million | $43.43 Million | ▼ -5.0 pp |
| 2020 | 98.3% | $163.67 Million | $166.53 Million | $181.67 Million | $17.99 Million | ▼ -0.6 pp |
| 2019 | 98.9% | $277.99 Million | $281.02 Million | $302.40 Million | $24.42 Million | ▼ -0.6 pp |
| 2018 | 99.5% | $245.11 Million | $246.26 Million | $258.69 Million | $13.58 Million | ▲ +0.1 pp |
| 2017 | 99.4% | $143.95 Million | $144.79 Million | $150.67 Million | $6.72 Million | ▲ +11.1 pp |
| 2016 | 88.3% | $6.44 Million | $7.30 Million | $11.18 Million | $4.73 Million | ▼ -6.1 pp |
| 2015 | 94.4% | $30.22 Million | $32.00 Million | $35.49 Million | $5.27 Million | ▼ -5.6 pp |
| 2014 | 100.0% | $-358.00K | $-358.00K | $194.00K | $552.00K | ▲ +126.2 pp |
| 2013 | -26.2% | $15.08 Million | $-57.46 Million | $18.14 Million | $3.06 Million | ▲ +18.8 pp |
| 2012 | -45.1% | $16.35 Million | $-36.28 Million | $18.86 Million | $2.50 Million | — |